pharmacological agent

pharmacological agent

[-loj′ik]
any oral, parenteral, or topical substance used to alleviate symptoms and treat or control a disease process or aid recovery from an injury.
References in periodicals archive ?
disease, development), and detection of an alteration in gene expression levels in response to specific biological stimuli such as a pharmacological agent.
In an extension of this strategy, termed pharmacological MRI (phMRI), the baseline state may be compared to conditions following administration of a pharmacological agent (e.
Reiter RJ, Tan DX, Kim SJ, Qi W, Melatonin as a pharmacological agent against oxidative damage to lipids and DNA.
PPL has successfully validated a new proprietary cell permeable peptide platform technology that has been shown to efficiently deliver an active pharmacological agent or cargo into a cell without disrupting the cell membrane.
As an extension of this research, Wu said, it may be possible to identify a pharmacological agent or bioactive agent that may have the desired effect on this gene toward reducing obesity-related cellular inflammatory response.
When treating any patient with a pharmacological agent it is important to monitor the patient closely throughout the treatment cycle and to tailor the treatment to best fit the patient's diagnosis, lifestyle, and other health management needs.
This proprietary platform technology has been shown to efficiently deliver an active pharmacological agent or cargo into a cell without disrupting the cell membrane.
point out that pharmacological cardioversion would be the preferred method of converting patients from AF to sinus rhythm provided there was a safe, effective and fast acting pharmacological agent available on the market.
is the first pharmacological agent approved for the treatment of symptomatic VMA
ADAC in particular emerges as an attractive pharmacological agent for therapeutic interventions in noise-induced cochlear injury in instances of both acute and extended noise exposures.
The acquired assets include all of Cyberkinetics' rights and regulatory filings for the Andara[TM] Oscillating Field Stimulator (OFS[TM]) technology for treatment of acute spinal cord injury, an investigational device designed to stimulate spinal cord repair and restore sensation; the rights to develop and commercialize a therapeutic product for peripheral nerve injury based on the Andara OFS neurostimulation technology; development and commercialization rights to certain derivatives of the pharmacological agent 4-aminopyridine that may be useful in the treatment of central and peripheral nervous system injury and disease; and certain other intellectual property and technology.
MCG solutions help to facilitate care team conversations by delivering guidelines that cover health topics such as imaging and diagnostic tests, procedures, durable medical equipment, pharmacological agents and more.

Full browser ?